Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy

Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs

(2017) Tatiane da Silva Araújo et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours

(2017) O. J. Onaolapo et al.   METABOLIC BRAIN DISEASE

Alterations in behaviour, cerebral cortical morphology and cerebral oxidative stress markers following aspartame ingestion

(2016) Adejoke Y. Onaolapo et al.   JOURNAL OF CHEMICAL NEUROANATOMY

Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm

(2016) Adejoke Yetunde Onaolapo et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Different dosing regimens of repeated ketamine administration have opposite effects on novelty processing in rats

(2016) Anett Schumacher et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods

(2015) Tomasz Pawełczyk et al.   BMC Psychiatry

Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms

(2015) Germana Silva Vasconcelos et al.   SCHIZOPHRENIA RESEARCH

Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice

(2015) Giuseppe D'Agostino et al.   Molecular Metabolism

Zinc modulates aluminium-induced oxidative stress and cellular injury in rat brain

(2014) Neha Singla et al.   Metallomics

Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review

(2014) Megan Anne Arroll et al.   Nutrition Journal

Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia

(2013) Herbert Y. Meltzer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways

(2013) Aline Santos Monte et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors

(2013) Ting-Ting Duan et al.   PSYCHOPHARMACOLOGY

Memantine Reverses Social Withdrawal Induced by Ketamine in Rats

(2013) Ezequiel Uribe et al.   Experimental Neurobiology

Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum

(2012) Fatemeh Khakpai et al.   BEHAVIOURAL BRAIN RESEARCH

Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D1 and D2 receptors in the caudate putamen of C57BL/6 mouse

(2012) Haiyun Xu et al.   LIFE SCIENCES

Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice

(2012) Manavi Chatterjee et al.   NEUROPHARMACOLOGY

Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: A randomized placebo-controlled clinical trial

(2012) Mehdi Sayyah et al.   NUTRITION

Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis

(2012) R Jayawardena et al.   Diabetology & Metabolic Syndrome

Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder

(2011) Anita Kulak et al.   BEHAVIOURAL BRAIN RESEARCH

Oxidative Stress in Schizophrenia

(2011) Iztok Grabnar et al.   Current Neuropharmacology

Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice

(2011) Oguz Mutlu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders

(2010) Molly K Larson et al.   Expert Review of Neurotherapeutics

Animal models of neuropsychiatric disorders

(2010) Eric J Nestler et al.   NATURE NEUROSCIENCE

Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway

(2010) H. Kamiyama et al.   NEUROSCIENCE

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

The Effect of Severe Zinc Deficiency and Zinc Supplement on Spatial Learning and Memory

(2009) S. Tahmasebi Boroujeni et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Insight into zinc signaling from dietary zinc deficiency

(2009) Atsushi Takeda et al.   BRAIN RESEARCH REVIEWS

The unchanging mortality gap for people with schizophrenia

(2009) Lydia A Chwastiak et al.   LANCET

Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

(2009) M. Margarita Behrens et al.   NEUROPHARMACOLOGY

Neuronal nicotinic acetylcholine receptors are modulated by zinc

(2009) Elizabeth Vázquez-Gómez et al.   NEUROPHARMACOLOGY

Antipsychotic-induced oxidative stress in Rat Brain

(2009) MÁrcio R. Martins et al.   NEUROTOXICITY RESEARCH

Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure

(2009) Takeshi Enomoto et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Zinc, Manganese, Calcium, Copper, and Cadmium Level in Scalp Hair Samples of Schizophrenic Patients

(2008) Md. Ashrafur Rahman et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Zinc at glutamatergic synapses

(2008) P. Paoletti et al.   NEUROSCIENCE

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

(2008) Věra Bubeníková-Valešová et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS